Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pregabalin
Drug ID BADD_D01835
Description Pregabalin is structurally similar to gamma-aminobutyric acid (GABA) - an inhibitory neurotransmitter.[A173995] It may be used to manage neuropathic pain, postherpetic neuralgia, and fibromyalgia among other conditions.[A187190] Although as per the FDA Label the mechanism of action has not been definitively defined, there is evidence that pregabalin exerts its effects by binding to the α2δ subunit of voltage-dependent calcium channels.[A187190][L7066] Pregabalin is marketed by Pfizer under the trade name Lyrica and Lyrica Cr (extended release).[L1006][L7066] It may have dependence liability if misused but the risk appears to be highest in patients with current or past substance use disorders.[A31161]
Indications and Usage Pregabalin is used for the management of neuropathic pain associated with diabetic peripheral neuropathy or spinal cord injury, and postherpetic neuralgia. It is not approved for the management of fibromyalgia or as adjuntive therapy for adult partial onset seizures.[FDA label]
Marketing Status Prescription
ATC Code N03AX16
DrugBank ID DB00230
KEGG ID D02716
MeSH ID D000069583
PubChem ID 5486971
TTD Drug ID D00WUF
NDC Product Code 69238-1315; 72189-032; 71335-1476; 0228-2860; 59762-1354; 63539-014; 59762-1364; 72189-028; 55700-956; 59762-1348; 64980-413; 71335-1791; 71335-2012; 71335-1744; 76420-124; 55700-827; 0071-1017; 72189-269; 43598-297; 72658-0811; 71205-556; 53869-1473; 80425-0129; 69539-012; 80425-0124; 55700-804; 71335-1745; 72189-035; 72189-023; 76420-099; 69097-957; 69367-326; 60219-1317; 76282-574; 27808-237; 55700-805; 80425-0123; 68788-7524; 76282-572; 76420-097; 76420-100; 59762-1576; 0071-1012; 42419-019; 76420-121; 42385-308; 76420-123; 71205-298; 69097-955; 63629-3369; 64980-414; 71335-1790; 72658-0812; 69097-956; 71205-876; 69097-961; 66174-0031; 69367-329; 72189-251; 80425-0185; 60219-1316; 72189-033; 60219-1314; 66651-915; 0228-2858; 60219-1310; 31722-614; 43598-296; 69238-1317; 72658-0849; 72658-0808; 55154-2431; 76420-118; 31722-615; 72658-0813; 0071-1018; 27808-235; 69539-015; 69367-330; 71610-356; 47781-381; 72606-008; 60687-506; 51407-510; 0228-2861; 0904-7004; 71335-1300; 43353-263; 47335-691; 63304-048; 71335-1822; 69097-954; 0071-1026; 60760-205; 62350-0072; 76420-098; 53869-1016; 55154-2430; 70518-2763; 72189-021; 71335-1505; 60219-1312; 63629-8198; 71335-2015; 71610-316; 53869-1018; 0071-1019; 0904-7005; 71335-2000; 0071-1016; 72888-051; 70518-2571; 71610-351; 0904-7002; 62332-121; 71610-358; 45865-126; 69367-331; 55700-904; 50436-0325; 0904-7003; 71610-331; 63539-024; 68788-7523; 76282-569; 70518-2568; 31722-616; 71610-334; 55700-817; 15894-0016; 71205-875; 71335-1459; 72189-020; 60687-495; 60687-517; 76282-568; 72888-049; 66039-926; 80425-0025; 47335-688; 63629-8196; 69238-1312; 72205-013; 68788-7656; 71205-304; 46708-125; 72658-0814; 69539-128; 70518-2948; 71205-338; 60687-484; 71205-871; 64980-417; 80425-0029; 53869-1014; 71610-365; 80425-0147; 53869-1010; 43353-414; 71610-333; 71610-328; 71335-1792; 63629-4181; 70518-2745; 50228-350; 43598-291; 72643-010; 71335-1758; 60219-1315; 50370-0013; 65015-857; 72189-034; 80425-0026; 66577-034; 80425-0152; 67877-466; 47335-687; 50090-5071; 0228-2862; 67877-465; 76282-573; 55700-964; 63629-8199; 43598-295; 43353-264; 47781-379; 70518-2980; 31722-611; 63629-8208; 60760-486; 64980-412; 16812-003; 70518-2525; 69539-018; 59762-1360; 59285-002; 0071-1027; 0228-2859; 80425-0166; 69238-1314; 60219-1311; 76282-570; 71205-869; 72640-002; 69539-129; 27808-236; 47781-380; 67877-467; 72606-007; 80425-0028; 76420-117; 70518-2762; 53869-1013; 72189-164; 72658-0809; 60760-509; 65862-790; 47335-690; 61919-503; 63629-8197; 71205-323; 80425-0116; 72189-019; 0071-1020; 50090-5038; 50090-5177; 27808-239; 55700-891; 70518-3345; 62332-123; 60219-1313; 70518-2689; 69367-325; 70518-2569; 67877-463; 69238-1311; 71610-317; 69367-328; 50228-355; 51407-511; 68788-7521; 70518-2364; 17337-0421; 70518-2290; 0071-1014; 69539-011; 50228-357; 69097-962; 69097-959; 0071-1013; 71610-335; 43598-294; 55289-257; 71610-319; 43353-675; 76282-575; 46708-120; 71205-396; 55111-882; 0071-1015; 43598-293; 47335-693; 72189-328; 63629-8195; 72189-045; 62332-119; 60687-473; 69238-1310; 59762-1342; 71610-071; 67877-468; 53869-1011; 72205-018; 62332-124; 0228-2857; 71610-329; 45865-108; 71610-330; 71610-361; 71205-608; 72205-017; 50228-354; 71205-873; 67877-462; 71610-357; 31722-612; 43598-298; 72205-012; 63629-8248; 62332-125; 68724-1235; 50228-356; 55289-569; 69238-1316; 60760-507; 59762-1351; 69097-958; 0228-2863; 69238-1313; 50228-351
Synonyms Pregabalin | (S)-3-(aminomethyl)-5-methylhexanoic acid | 3-isobutyl GABA | 3 isobutyl GABA | GABA, 3-isobutyl | 3-(aminomethyl)-5-methylhexanoic acid | (R-)-3-isobutyl GABA | (S+)-3-isobutyl GABA | Lyrica | CI 1008 | 1008, CI | CI-1008 | CI1008
Chemical Information
Molecular Formula C8H17NO2
CAS Registry Number 148553-50-8
SMILES CC(C)CC(CC(=O)O)CN
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Bradypnoea22.02.01.0020.000944%Not Available
Breast abscess21.05.03.003; 18.06.02.002; 11.01.02.002--Not Available
Breast cancer16.10.01.001; 21.05.01.003--Not Available
Breast discharge21.05.05.0010.000354%Not Available
Breast enlargement21.05.04.0010.000236%Not Available
Breast mass21.05.04.0020.000826%Not Available
Breast neoplasm21.05.01.004; 16.10.02.0010.000236%Not Available
Breast pain21.05.05.003--
Breath odour07.01.06.002--Not Available
Bronchiectasis22.03.02.005--Not Available
Bronchiolitis11.05.04.008; 22.03.02.004--Not Available
Bronchitis22.07.01.001; 11.01.09.0010.005072%
Bruxism19.11.03.001; 07.01.06.008--Not Available
Bundle branch block02.03.01.009--Not Available
Bundle branch block left02.03.01.0070.000354%Not Available
Burning sensation17.02.06.001; 08.01.09.0290.016985%Not Available
Bursitis15.04.01.001--Not Available
C-reactive protein increased13.09.01.0070.003067%Not Available
Calcium metabolism disorder14.04.01.002--Not Available
Calculus bladder20.04.02.002--Not Available
Calculus urinary20.04.02.0010.000236%Not Available
Capillary fragility increased13.01.02.022--Not Available
Cardiac arrest02.03.04.001--
Cardiac failure02.05.01.0010.002123%
Cardiac failure acute02.05.01.005--Not Available
Cardiac failure congestive02.05.01.002--Not Available
Cardio-respiratory arrest22.02.06.007; 02.03.04.002--Not Available
Cardiogenic shock24.06.02.006; 02.05.01.003--Not Available
Cardiomegaly02.04.02.001--Not Available
Cardiomyopathy02.04.01.001--Not Available
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 55 Pages